Healthy volunteers needed to test new Drug's absorption and food effects
NCT ID NCT07226817
First seen Jun 26, 2026 · Last updated Aug 13, 2026 · Updated 5 times
Summary
This study in 140 healthy adults tests how well different tablet versions of the drug BMS-986435 are absorbed into the body and whether taking it with food changes absorption. Participants will receive one or more doses of the drug in different tablet forms. The goal is to pick the best tablet and understand food effects for future studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BMS-986435 (also called MYK-224)
- What this could lead to
- If successful, this study will help determine the best tablet form and dosing conditions for future trials of BMS-986435.
- What could go wrong
- This is an early Phase 1 study in healthy people, not patients. It only measures drug levels and safety, not whether the drug works for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Quotient Miami
RECRUITINGMiami, Florida, 33126, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults